The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Photograph: Amit......
Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement report by the US Food and Drug......
Some of the popular brands that would be impacted include Phensedyl (Abbott), Tixylix (Abbott), Gluconorm PG (Lupin), Ascoril D (Glenmark), Solvin Cold (Ipca), D Cold Total (Paras Pharma). The......
Abbott is challenging the ban on its popular codeine-based cough syrup on the grounds it was not given a chance to defend itself. The Delhi High Court restrained the government from enforcing a ban......
Govt bans brands with annual sales worth Rs 3,728 crore. Image: Companies likely to be most affected are Pfizer, Abbott and Macleods Pharma. Photograph: Reuters The government has......